发明名称 METHODS OF INDUCING A T CELL MEDIATED IMMUNE RESPONSE BY ADMINISTERING ANTIGEN PRESENTING B CELLS
摘要 We teach a strategy to obtain large quantities of desired APCs, activated B cells, which are superior in their capacity to present tumor protein antigen in a multiadministration protocol. Human B cells can be obtained from peripheral blood in large numbers. These cells can be activated in vitro by coculture with CD40L (CD40-B cells) and an immunosuppressive agent such as cyclosporin A. They can expanded up to 1x10<SUP>3 </SUP>to 1x10<SUP>4 </SUP>fold in 2 weeks or 1x10<SUP>5 </SUP>to 1x10<SUP>6 </SUP>fold in 2 months. We demonstrate these cells are most efficient APCs comparable to DCs in stimulating allogeneic CD4<SUP>+</SUP> CD45RA<SUP>+</SUP>, CD4<SUP>+</SUP> CD45RO<SUP>+</SUP>, and CD8<SUP>+</SUP> T cells. In contrast to DCs, CD40-B cells are fully functional even in the presence of immunosuppressive cytokines such as IL-10 and TGFbeta.
申请公布号 US2007031811(A1) 申请公布日期 2007.02.08
申请号 US20020186416 申请日期 2002.07.01
申请人 DANA-FARBER CANCER INSTITUTE, INC. 发明人 SCHULTZE JOACHIM L.;FREEMAN GORDON J.;GRIBBEN JOHN G.;NADLER LEE M.
分类号 A01N1/02;C12N5/02;C12N5/0781 主分类号 A01N1/02
代理机构 代理人
主权项
地址